IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,004,745 | +97.9% | 126,323 | +135.3% | 0.00% | – |
| Q2 2023 | $1,013,055 | +135.0% | 53,686 | -40.3% | 0.00% | – |
| Q4 2018 | $431,000 | -97.4% | 89,863 | -94.8% | 0.00% | -100.0% |
| Q2 2018 | $16,901,000 | -39.9% | 1,737,000 | -35.0% | 0.01% | -35.7% |
| Q1 2018 | $28,114,000 | +45.9% | 2,672,400 | -11.1% | 0.01% | +55.6% |
| Q4 2017 | $19,272,000 | -10.4% | 3,006,600 | +7.0% | 0.01% | -18.2% |
| Q3 2017 | $21,503,000 | +747.9% | 2,810,900 | +197.0% | 0.01% | +1000.0% |
| Q3 2016 | $2,536,000 | -13.0% | 946,301 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $2,915,000 | -63.8% | 946,301 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $8,062,000 | -37.2% | 946,301 | 0.0% | 0.00% | -42.9% |
| Q4 2015 | $12,841,000 | +41.4% | 946,301 | 0.0% | 0.01% | +75.0% |
| Q3 2015 | $9,084,000 | -27.7% | 946,301 | +8.3% | 0.00% | -33.3% |
| Q2 2015 | $12,569,000 | – | 874,050 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |